DAVID GEHLKEN: Open Payments
NPI 1912195744 · CHULA VISTA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 13 payments from 5 companies in 2025. Trend: 2023 $101 · 2024 $604 · 2025 $351
Food & beverage: $286Education: $65
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 8 | $213 |
| Medtronic, Inc. | 2 | $47 |
| Aimmune Therapeutics, Inc. | 1 | $43 |
| Dexcom, Inc. | 1 | $26 |
| Abbott Laboratories | 1 | $22 |
Products named: Ozempic, VOWST, MAZOR X SYSTEM, Dexcom G6 Transmitter, Wegovy, FREESTYLE LIBRE 3, AQUAMANTYS(TM).
Industry payments across CA — which companies pay providers there.
